December 16, 2008 07:45 ET

Aggressive Growth and Profitability in Q3 for QUMAS

JERSEY CITY, NJ--(Marketwire - December 16, 2008) - QUMAS, the leading provider of Compliance Solutions to highly regulated companies, today announced further growth and profitability in Q3, 2008. This will keep QUMAS on target to deliver 30% growth year on year.

Despite the global economic downturn, QUMAS continues to grow the business, beating software and services targets quarter on quarter, and delivering profitability to its shareholders. This growth and profitability reinforces the QUMAS position as the market leader for Regulatory Compliance Solutions. It also demonstrates that the industry chooses QUMAS not only for its comprehensive solutions, but for its stability as an organization, providing a safe, strong option to clients and prospects through these turbulent times.

"As we continue to grow the company aggressively, it is important to us that the industry recognizes that we are the dominant player in this market," said Kevin O'Leary, CEO of QUMAS. "Profitable companies such as QUMAS have a proven reputation and stability, and as such will provide the strength that clients need to drive through these difficult times."

In recent months, QUMAS has announced new client acquisitions such as Lantheus Medical Imaging, Ferndale Laboratories Inc., and Avigen in the U.S. and PharmaZell in Europe to name but a few. These engagements include two seven-figure deals, further confirming the strength of the QUMAS Compliance Solution offerings.

About QUMAS:

QUMAS is the leader in Enterprise Regulatory Compliance Solutions with more than 250 global customer deployments and over a decade of experience helping companies in highly regulated industries. The QUMAS solution facilitates an informed response to Compliance challenges across the organization, and provides better overall governance and predictability of business performance as well as meaningful reporting to stakeholders.

For more information visit

Contact Information